Artificial Intelligence in Precision Medicine
Artificial Intelligence in Precision Medicine market is segmented by region (country), players, b ... Read More
1 Study Coverage 1.1 Personalized Cancer Medicine Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Introduction 1.2 Global Personalized Cancer Medicine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Personalized Cancer Medicine Market Size for the Year 2017-2028 1.2.2 Global Personalized Cancer Medicine Market Size for the Year 2017-2028 1.3 Personalized Cancer Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Personalized Cancer Medicine in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Personalized Cancer Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Personalized Cancer Medicine Market Dynamics 1.4.1 Personalized Cancer Medicine Industry Trends 1.4.2 Personalized Cancer Medicine Market Drivers 1.4.3 Personalized Cancer Medicine Market Challenges 1.4.4 Personalized Cancer Medicine Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Personalized Cancer Medicine by Type 2.1 Personalized Cancer Medicine Market Segment by Type 2.1.1 Monoclonal Antibodies 2.1.2 Personalized Cancer Vaccines 2.1.3 Other 2.2 Global Personalized Cancer Medicine Market Size by Type (2017, 2022 & 2028) 2.3 Global Personalized Cancer Medicine Market Size by Type (2017-2028) 2.4 United States Personalized Cancer Medicine Market Size by Type (2017, 2022 & 2028) 2.5 United States Personalized Cancer Medicine Market Size by Type (2017-2028) 3 Personalized Cancer Medicine by Application 3.1 Personalized Cancer Medicine Market Segment by Application 3.1.1 Breast Cancer 3.1.2 Lung Cancer 3.1.3 Chronic Myeloid Leukaemia 3.1.4 Bowel Cancer 3.1.5 Other Cancer 3.2 Global Personalized Cancer Medicine Market Size by Application (2017, 2022 & 2028) 3.3 Global Personalized Cancer Medicine Market Size by Application (2017-2028) 3.4 United States Personalized Cancer Medicine Market Size by Application (2017, 2022 & 2028) 3.5 United States Personalized Cancer Medicine Market Size by Application (2017-2028) 4 Global Personalized Cancer Medicine Competitor Landscape by Company 4.1 Global Personalized Cancer Medicine Market Size by Company 4.1.1 Top Global Personalized Cancer Medicine Companies Ranked by Revenue (2021) 4.1.2 Global Personalized Cancer Medicine Revenue by Player (2017-2022) 4.2 Global Personalized Cancer Medicine Concentration Ratio (CR) 4.2.1 Personalized Cancer Medicine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Personalized Cancer Medicine in 2021 4.2.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Personalized Cancer Medicine Headquarters, Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Type 4.3.1 Global Personalized Cancer Medicine Headquarters and Area Served 4.3.2 Global Personalized Cancer Medicine Companies Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Personalized Cancer Medicine Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Personalized Cancer Medicine Market Size by Company 4.5.1 Top Personalized Cancer Medicine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Personalized Cancer Medicine Revenue by Players (2020, 2021 & 2022) 5 Global Personalized Cancer Medicine Market Size by Region 5.1 Global Personalized Cancer Medicine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Personalized Cancer Medicine Market Size by Region (2017-2028) 5.2.1 Global Personalized Cancer Medicine Market Size by Region: 2017-2022 5.2.2 Global Personalized Cancer Medicine Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Personalized Cancer Medicine Market Size YoY Growth 2017-2028 6.1.2 North America Personalized Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Personalized Cancer Medicine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Personalized Cancer Medicine Market Size YoY Growth 2017-2028 6.3.2 Europe Personalized Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Personalized Cancer Medicine Market Size YoY Growth 2017-2028 6.4.2 Latin America Personalized Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Personalized Cancer Medicine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Personalized Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Abbott 7.1.1 Abbott Company Details 7.1.2 Abbott Business Overview 7.1.3 Abbott Personalized Cancer Medicine Introduction 7.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2017-2022) 7.1.5 Abbott Recent Development 7.2 Merck 7.2.1 Merck Company Details 7.2.2 Merck Business Overview 7.2.3 Merck Personalized Cancer Medicine Introduction 7.2.4 Merck Revenue in Personalized Cancer Medicine Business (2017-2022) 7.2.5 Merck Recent Development 7.3 Novartis 7.3.1 Novartis Company Details 7.3.2 Novartis Business Overview 7.3.3 Novartis Personalized Cancer Medicine Introduction 7.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2017-2022) 7.3.5 Novartis Recent Development 7.4 Amgen 7.4.1 Amgen Company Details 7.4.2 Amgen Business Overview 7.4.3 Amgen Personalized Cancer Medicine Introduction 7.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2017-2022) 7.4.5 Amgen Recent Development 7.5 Celgene 7.5.1 Celgene Company Details 7.5.2 Celgene Business Overview 7.5.3 Celgene Personalized Cancer Medicine Introduction 7.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2017-2022) 7.5.5 Celgene Recent Development 7.6 Bayer 7.6.1 Bayer Company Details 7.6.2 Bayer Business Overview 7.6.3 Bayer Personalized Cancer Medicine Introduction 7.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2017-2022) 7.6.5 Bayer Recent Development 7.7 Roche 7.7.1 Roche Company Details 7.7.2 Roche Business Overview 7.7.3 Roche Personalized Cancer Medicine Introduction 7.7.4 Roche Revenue in Personalized Cancer Medicine Business (2017-2022) 7.7.5 Roche Recent Development 7.8 Astellas 7.8.1 Astellas Company Details 7.8.2 Astellas Business Overview 7.8.3 Astellas Personalized Cancer Medicine Introduction 7.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2017-2022) 7.8.5 Astellas Recent Development 7.9 Astrazeneca 7.9.1 Astrazeneca Company Details 7.9.2 Astrazeneca Business Overview 7.9.3 Astrazeneca Personalized Cancer Medicine Introduction 7.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2017-2022) 7.9.5 Astrazeneca Recent Development 7.10 Johnson & Johnson 7.10.1 Johnson & Johnson Company Details 7.10.2 Johnson & Johnson Business Overview 7.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction 7.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2017-2022) 7.10.5 Johnson & Johnson Recent Development 7.11 Agilent 7.11.1 Agilent Company Details 7.11.2 Agilent Business Overview 7.11.3 Agilent Personalized Cancer Medicine Introduction 7.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2017-2022) 7.11.5 Agilent Recent Development 7.12 Takeda 7.12.1 Takeda Company Details 7.12.2 Takeda Business Overview 7.12.3 Takeda Personalized Cancer Medicine Introduction 7.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2017-2022) 7.12.5 Takeda Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Personalized Cancer Medicine Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Personalized Cancer Medicine Market Trends Table 3. Personalized Cancer Medicine Market Drivers Table 4. Personalized Cancer Medicine Market Challenges Table 5. Personalized Cancer Medicine Market Restraints Table 6. Global Personalized Cancer Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Personalized Cancer Medicine Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Personalized Cancer Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Personalized Cancer Medicine Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Personalized Cancer Medicine Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Personalized Cancer Medicine Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Personalized Cancer Medicine Revenue Share by Player, 2017-2022 Table 13. Global Personalized Cancer Medicine Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Personalized Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2021) Table 15. Top Players of Personalized Cancer Medicine in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Personalized Cancer Medicine Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Personalized Cancer Medicine Players in United States Market, Ranking by Revenue (2021) Table 20. United States Personalized Cancer Medicine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Personalized Cancer Medicine Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Personalized Cancer Medicine Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Personalized Cancer Medicine Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Personalized Cancer Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Personalized Cancer Medicine Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Personalized Cancer Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Personalized Cancer Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Personalized Cancer Medicine Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Abbott Company Details Table 31. Abbott Business Overview Table 32. Abbott Personalized Cancer Medicine Product Table 33. Abbott Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 34. Abbott Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Personalized Cancer Medicine Product Table 38. Merck Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. Novartis Company Details Table 41. Novartis Business Overview Table 42. Novartis Personalized Cancer Medicine Product Table 43. Novartis Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 44. Novartis Recent Development Table 45. Amgen Company Details Table 46. Amgen Business Overview Table 47. Amgen Personalized Cancer Medicine Product Table 48. Amgen Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 49. Amgen Recent Development Table 50. Celgene Company Details Table 51. Celgene Business Overview Table 52. Celgene Personalized Cancer Medicine Product Table 53. Celgene Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 54. Celgene Recent Development Table 55. Bayer Company Details Table 56. Bayer Business Overview Table 57. Bayer Personalized Cancer Medicine Product Table 58. Bayer Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 59. Bayer Recent Development Table 60. Roche Company Details Table 61. Roche Business Overview Table 62. Roche Personalized Cancer Medicine Product Table 63. Roche Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 64. Roche Recent Development Table 65. Astellas Company Details Table 66. Astellas Business Overview Table 67. Astellas Personalized Cancer Medicine Product Table 68. Astellas Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 69. Astellas Recent Development Table 70. Astrazeneca Company Details Table 71. Astrazeneca Business Overview Table 72. Astrazeneca Personalized Cancer Medicine Product Table 73. Astrazeneca Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 74. Astrazeneca Recent Development Table 75. Johnson & Johnson Company Details Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Personalized Cancer Medicine Product Table 78. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 79. Johnson & Johnson Recent Development Table 80. Agilent Company Details Table 81. Agilent Business Overview Table 82. Agilent Personalized Cancer Medicine Product Table 83. Agilent Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 84. Agilent Recent Development Table 85. Takeda Company Details Table 86. Takeda Business Overview Table 87. Takeda Personalized Cancer Medicine Product Table 88. Takeda Revenue in Personalized Cancer Medicine Business (2017-2022) & (US$ Million) Table 89. Takeda Recent Development Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Personalized Cancer Medicine Product Picture Figure 2. Global Personalized Cancer Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Personalized Cancer Medicine Market Size 2017-2028 (US$ Million) Figure 4. United States Personalized Cancer Medicine Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Personalized Cancer Medicine Market Size 2017-2028 (US$ Million) Figure 6. United States Personalized Cancer Medicine Market Share in Global 2017-2028 Figure 7. Personalized Cancer Medicine Report Years Considered Figure 8. Product Picture of Monoclonal Antibodies Figure 9. Product Picture of Personalized Cancer Vaccines Figure 10. Product Picture of Other Figure 11. Global Personalized Cancer Medicine Market Share by Type in 2022 & 2028 Figure 12. Global Personalized Cancer Medicine Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Personalized Cancer Medicine Market Share by Type (2017-2028) Figure 14. United States Personalized Cancer Medicine Market Share by Type in 2022 & 2028 Figure 15. United States Personalized Cancer Medicine Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Personalized Cancer Medicine Market Share by Type (2017-2028) Figure 17. Product Picture of Breast Cancer Figure 18. Product Picture of Lung Cancer Figure 19. Product Picture of Chronic Myeloid Leukaemia Figure 20. Product Picture of Bowel Cancer Figure 21. Product Picture of Other Cancer Figure 22. Global Personalized Cancer Medicine Market Share by Application in 2022 & 2028 Figure 23. Global Personalized Cancer Medicine Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Personalized Cancer Medicine Market Share by Application (2017-2028) Figure 25. United States Personalized Cancer Medicine Market Share by Application in 2022 & 2028 Figure 26. United States Personalized Cancer Medicine Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Personalized Cancer Medicine Market Share by Application (2017-2028) Figure 28. North America Personalized Cancer Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Personalized Cancer Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Personalized Cancer Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Personalized Cancer Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Personalized Cancer Medicine Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. U.A.E Personalized Cancer Medicine Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 57. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 59. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 60. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 61. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 62. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 63. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 64. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 65. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 66. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 67. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed
Abbott Merck Novartis Amgen Celgene Bayer Roche Astellas Astrazeneca Johnson & Johnson Agilent Takeda
Artificial Intelligence in Precision Medicine market is segmented by region (country), players, b ... Read More
Chromosome Enumeration Probes (CEP) market is segmented by region (country), players, by Type and ... Read More
Hematology Probes market is segmented by region (country), players, by Type and by Application. P ... Read More
Microdeletion Probes market is segmented by region (country), players, by Type and by Application ... Read More